Genetic Predisposition to Disease Clinical Trial
Official title:
Helix Research Network
The Helix Research Network ("HRN") is a network of academic, public, and/or private healthcare organizations that are committed to advancing medical research and improving human health through large-scale genomics research and acceleration of the integration of genomic and other omics data into clinical care.
The network will create a large-scale clinicogenomics dataset, which will support research to discover molecular and genetic determinants of disease risk, disease progression, treatment response, health economic outcomes, social or behavioral determinants of health, targets for therapeutic intervention, risk stratification, clinical implementation, and other clinical indicators of interest. This clinicogenomics dataset will be used to reveal molecular and/or genetic factors that could improve the diagnosis or medical treatment of individual participants and includes a process to share individual results with participants. Participants will also receive annual reports on study outcomes and the impact of HRN, as such information becomes available. Institutional membership in HRN will consist of Helix and member healthcare systems (herein referred to as "HRN Member Site(s)"). The Helix Research Network is a multi-center research program that will enroll an unlimited number of participants. Participants will be recruited concurrently from HRN Member Sites. In some cases, HRN Member Sites may recruit participants from multiple clinical sites. Participants who meet the enrollment criteria established in this protocol will be enrolled if they or their legally authorized representative(s) provide informed consent in accordance with all applicable regulations and sIRB requirements. Participants will be enrolled until withdrawal from the study or end of the study. Participants may be recruited at any point during the study period, until the recruitment goals established by the protocol are met. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05020574 -
Microbiome and Association With Implant Infections
|
Phase 2 | |
| Recruiting |
NCT04390269 -
Immunogenetics Predictors With COVID-19
|
||
| Recruiting |
NCT04427163 -
Assesment of Multiomics Profiles in Health and Disease.
|
||
| Completed |
NCT03597659 -
PheWAS of a Polygenic Predictor of Thyroid Function
|
||
| Active, not recruiting |
NCT04634032 -
Gene Expression and DNA Variation Analysis of Sacs to Identify the Pathophysiology of Indirect Inguinal Hernia
|
||
| Completed |
NCT04145817 -
Breast Cancer Risk After Diagnostic Gene Sequencing
|
N/A | |
| Recruiting |
NCT04600544 -
Russian Disc Degeneration Study
|
||
| Not yet recruiting |
NCT04788927 -
Development of a Predictive Model for the Risk of Metastatic Disease in PPGLs, a Retrospective Cohort Study
|
||
| Not yet recruiting |
NCT03234140 -
Constitutional Genetics in Follicular Lymphoma
|
N/A | |
| Completed |
NCT01973075 -
Genetic Etiology in Premature Ovarian Insufficiency
|
N/A | |
| Completed |
NCT00555503 -
Registry of Mastectomy for Breast Cancer Risk Reduction
|
N/A | |
| Active, not recruiting |
NCT05524909 -
Full-scale Intervention Study: Genetic Risk Communication and Wearables
|
N/A | |
| Suspended |
NCT04151368 -
Surgical and Patient Reported Outcomes of Robotic Nipple-Sparing Mastectomy
|
N/A | |
| Completed |
NCT02422511 -
Genomic Sequencing for Childhood Risk and Newborn Illness
|
N/A | |
| Completed |
NCT00677495 -
Gluten-free Diet in Gluten-genetically Predisposed Subjects
|
N/A | |
| Recruiting |
NCT05759143 -
Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing
|
N/A | |
| Enrolling by invitation |
NCT05721326 -
Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition
|
N/A | |
| Active, not recruiting |
NCT05685810 -
Genetic Determinants of Kidney Disease in People of African Ancestry With HIV
|
||
| Recruiting |
NCT04903782 -
Cancer Predisposition Testing by Family-based Whole-genome Sequencing (WGS) in Every Child With Newly Diagnosed Cancer
|
||
| Recruiting |
NCT05205356 -
VIGOR: Virtual Genome Center for Infant Health
|